Team develops DNA compounds that could help treat lupus
A research team led by a University of Iowa investigator has generated DNA-like compounds that effectively inhibit the cells responsible for systemic lupus erythematosus -- the most common and serious form of lupus. There currently is no cure for this chronic autoimmune condition that damages the skin, joints and internal organs and affects an estimated one million Americans. The team, which included researchers at Boston University School of Medicine, demonstrated the anti-inflammatory effects of class R inhibitory oligonucleotides in laboratory experiments. The findings, which could eventually lead to new treatments, appear May 28 in BioMed Central's open access journal Arthritis Research and Therapy.
"The increased potency of class R inhibitory oligonucleotides for certain cells involved in lupus flare-ups could help patients by providing specific inhibition, yet allowing them to generate a protective immune response when needed," said the study's lead author, Petar Lenert, M.D., Ph.D., assistant professor of internal medicine at the University of Iowa Roy Carver College of Medicine.
During periodic flare-ups in people with lupus, the immune system overreacts and mistakenly attacks cells and tissues throughout the body, resulting in a range of symptoms including inflammation, pain and a characteristic "butterfly rash" across the cheeks.
Using human cell lines and isolated mouse cells, Lenert and his colleagues showed that the DNA-like compounds were able to selectively reduce the activity of two types of immune cells called autoreactive B cells and dendritic cells. When given to mice with lupus, the compounds delayed death and reduced kidney damage, proving their effectiveness.
"With further testing, we hope that class R inhibitory oligonucleotides may become another weapon in the fight against lupus," Lenert said.
Lupus prevalence varies by country and ethnicity. It is much more common in women than men; nine out of 10 people with lupus are female. Lupus also is three times more common in African-American women than in Caucasian women and is more prevalent in women of Latino, Asian and Native American descent.
Source: University of Iowa
- Immune cell's role in lupus nephritis demonstratedTue, 1 Jun 2010, 10:26:18 EDT
- Alternative therapy for lupus nephritisWed, 15 Apr 2009, 18:16:17 EDT
- Kidney transplants generally safe for lupus patientsSat, 31 Oct 2009, 14:37:03 EDT
- Scripps research scientists find key culprits in lupusMon, 29 Jun 2009, 18:44:40 EDT
- Lupus Research Institute-funded study points to increased risk for lupus in menThu, 2 Sep 2010, 11:23:46 EDT
Articles on the same topic
- Development of DNA drugs gives hope to lupus patientsWed, 27 May 2009, 19:44:51 EDT
- Team develops DNA compounds that could help treat lupusfrom Science CentricThu, 28 May 2009, 10:21:19 EDT
- Development of DNA drugs gives hope to lupus patientsfrom Science CentricThu, 28 May 2009, 8:07:32 EDT
- Team develops DNA compounds that could help treat lupusfrom Biology News NetThu, 28 May 2009, 0:56:56 EDT
- DNA Compounds Could Help Treat Lupusfrom Science DailyWed, 27 May 2009, 22:21:16 EDT
- Team develops DNA compounds that could help treat lupusfrom PhysorgWed, 27 May 2009, 19:42:31 EDT
- Team develops DNA compounds that could help treat lupusfrom Science BlogWed, 27 May 2009, 19:42:14 EDT
Latest Science NewsletterGet the latest and most popular science news articles of the week in your Inbox! It's free!
Learn more about
Check out our next project, Biology.Net
From other science news sites
Popular science news articles
- Even with defects, graphene is strongest material in the world
- Detection of the cosmic gamma ray horizon: Measures all the light in the universe since the Big Bang
- Genetic engineering alters mosquitoes' sense of smell
- Allosaurus fed more like a falcon than a crocodile, new study finds
- 'Popcorn' particle pathways promise better lithium-ion batteries